Objective: The aim of this study was to assess the quality of global clinical practice guidelines (CPGs) on gout.
Methods: We systematically searched MEDLINE, CBM (Chinese Biomedical Literature database), GIN (Guidelines International Network), NICE (National Institute for Health and Clinical Excellence), NGC (National Guideline Clearinghouse), WHO (World Health Organization), SIGN (Scottish Intercollegiate Guidelines Network), DynaMed, UpToDate, and Best Practice databases from their inception until January 2017 to identify and select CPGs related to gout. Two reviewers independently assessed the eligible gout CPGs using the AGREE II instrument.
Results: We evaluated 15 CPGs published between 2007 and 2017, produced by 13 different developers. Quality of evidence and strength of recommendations were presented in 14 (93%) and 13 (87%) CPGs, respectively. The mean scores (±SD) for each AGREE II domain were as follows: (i) scope and purpose: 75% (±17%), (ii) stakeholder involvement: 39% (±19%), (iii) rigor of development: 43% (±17%), (iv) clarity and presentation: 82% (±14%), (v) applicability: 31% (±12%), and (vi) editorial independence: 23% (±29%).
Conclusions: The quality of gout CPGs was suboptimal, and various incompatible grading systems of quality of evidence and strength of recommendations were used. The use of a standardized international grading system is essential to ensure high methodological quality of gout CPGs. Tools such as AGREE II could substantially improve the development and update of future gout CPGs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/RHU.0000000000000921 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of Recommendations Made by Committee Members with and without Financial Conflict of Interest on Japanese Guideline of Treatment of Hyperuricemia and Gout, Third Edition.
JMA J
October 2023
Department of Rheumatology, Sanno Medical Center, Tokyo, Japan.
Clinical practice guidelines (CPGs) consist of clinical questions (CQs) and corresponding recommendations. Considering the estimation of body of evidence, patients' opinions, and medical economics, recommendations can vary depending on the votes of the committee members of CPGs. Taking this into consideration, concerns have already been raised on how financial conflict of interest (COI) potentially influences recommendations.
View Article and Find Full Text PDFWhat are the core recommendations for gout management in first line and specialist care? Systematic review of clinical practice guidelines.
BMC Rheumatol
June 2023
The University of Western Australia, Western Australian Centre for Rural Health, Geraldton, WA, Australia.
Background: Gout is the most common inflammatory arthritis, increasing in prevalence and burden. Of the rheumatic diseases, gout is the best-understood and potentially most manageable condition. However, it frequently remains untreated or poorly managed.
View Article and Find Full Text PDFEpigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus.
Nat Commun
December 2021
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Article Synopsis
- * The study identified 100 significant CpG sites that account for 11.6% of serum urate variance, particularly noting five CpGs associated with SLC2A9, a major gene influencing serum urate levels.
- * Additionally, some of these CpGs also appear to mediate effects of genetic variants related to serum urate and are linked to metabolic syndrome, suggesting a potential blood DNA methylation signature for assessing cardiometabolic risk factors.
Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic review.
Syst Rev
April 2021
Gout Laboratory, The Affiliated Hospital of Qingdao University, No.16 Jiangsu Road, Qingdao, China.
Background: The Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist was used to assess the reporting quality of 2009-2019 clinical practice guidelines (CPGs) regarding gout and hyperuricemia, aimed to improve the reporting quality of future guidelines.
Methods: We searched PubMed, the Chinese Biomedical Literature database, the Wanfang Database, and the China National Knowledge Infrastructure from January 2009 to June 2019 for guidelines regarding gout and hyperuricemia. We also searched the websites of guideline development organizations (the Guidelines International Network, the National Institute for Health and Clinical Excellence, the American College of Rheumatology, and the European League Against Rheumatism (EULAR)).
Assessing the Quality of Global Clinical Practice Guidelines on Gout Using AGREE II Instrument.
J Clin Rheumatol
March 2020
Institute of Mathematical Statistics and Actuarial Science, University of Bern, Bern.
Objective: The aim of this study was to assess the quality of global clinical practice guidelines (CPGs) on gout.
Methods: We systematically searched MEDLINE, CBM (Chinese Biomedical Literature database), GIN (Guidelines International Network), NICE (National Institute for Health and Clinical Excellence), NGC (National Guideline Clearinghouse), WHO (World Health Organization), SIGN (Scottish Intercollegiate Guidelines Network), DynaMed, UpToDate, and Best Practice databases from their inception until January 2017 to identify and select CPGs related to gout. Two reviewers independently assessed the eligible gout CPGs using the AGREE II instrument.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!